12.23.2025Press ReleaseIR NewsSanten Launches Verkazia® (Ciclosporin Eye Drops (III) ) in China For the Treatment of Severe Vernal Keratoconjunctivitis (VKC) in Children and Young Adults
December 23, 2025 – Osaka, Japan – Santen Pharmaceutical Co., Ltd. (hereinafter Santen) today announ...
Publisher
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
December 23, 2025 – Osaka, Japan – Santen Pharmaceutical Co., Ltd. (hereinafter Santen) today announ...
Source route
Continue on santen.com
Leave the platform to read the original full article on the publisher site.
Source: Santen Pharmaceutical
Scope: Industry
Related coverage
More related coverage
Mar.23.2026R & DBristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo®(nivolumab)
This material is intended to notify the press release issued on March 20 (local time) by Bristol Mye...